These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 26857492)

  • 1. MSRV envelope protein is a potent, endogenous and pathogenic agonist of human toll-like receptor 4: Relevance of GNbAC1 in multiple sclerosis treatment.
    Madeira A; Burgelin I; Perron H; Curtin F; Lang AB; Faucard R
    J Neuroimmunol; 2016 Feb; 291():29-38. PubMed ID: 26857492
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preclinical and early clinical development of GNbAC1, a humanized IgG4 monoclonal antibody targeting endogenous retroviral MSRV-Env protein.
    Curtin F; Perron H; Kromminga A; Porchet H; Lang AB
    MAbs; 2015; 7(1):265-75. PubMed ID: 25427053
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment against human endogenous retrovirus: a possible personalized medicine approach for multiple sclerosis.
    Curtin F; Perron H; Faucard R; Porchet H; Lang AB
    Mol Diagn Ther; 2015 Oct; 19(5):255-65. PubMed ID: 26376649
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human Endogenous Retrovirus and Neuroinflammation in Chronic Inflammatory Demyelinating Polyradiculoneuropathy.
    Faucard R; Madeira A; Gehin N; Authier FJ; Panaite PA; Lesage C; Burgelin I; Bertel M; Bernard C; Curtin F; Lang AB; Steck AJ; Perron H; Kuntzer T; Créange A
    EBioMedicine; 2016 Apr; 6():190-198. PubMed ID: 27211560
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A phase IIa randomised clinical study of GNbAC1, a humanised monoclonal antibody against the envelope protein of multiple sclerosis-associated endogenous retrovirus in multiple sclerosis patients.
    Derfuss T; Curtin F; Guebelin C; Bridel C; Rasenack M; Matthey A; Du Pasquier R; Schluep M; Desmeules J; Lang AB; Perron H; Faucard R; Porchet H; Hartung HP; Kappos L; Lalive PH
    Mult Scler; 2015 Jun; 21(7):885-93. PubMed ID: 25392325
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inflammatory response of endothelial cells to a human endogenous retrovirus associated with multiple sclerosis is mediated by TLR4.
    Duperray A; Barbe D; Raguenez G; Weksler BB; Romero IA; Couraud PO; Perron H; Marche PN
    Int Immunol; 2015 Nov; 27(11):545-53. PubMed ID: 25957268
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GNbAC1, a humanized monoclonal antibody against the envelope protein of multiple sclerosis-associated endogenous retrovirus: a first-in-humans randomized clinical study.
    Curtin F; Lang AB; Perron H; Laumonier M; Vidal V; Porchet HC; Hartung HP
    Clin Ther; 2012 Dec; 34(12):2268-78. PubMed ID: 23200102
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human endogenous retrovirus W in brain lesions: Rationale for targeted therapy in multiple sclerosis.
    van Horssen J; van der Pol S; Nijland P; Amor S; Perron H
    Mult Scler Relat Disord; 2016 Jul; 8():11-8. PubMed ID: 27456869
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of transcribed human endogenous retrovirus W env loci clarifies the origin of multiple sclerosis-associated retrovirus env sequences.
    Laufer G; Mayer J; Mueller BF; Mueller-Lantzsch N; Ruprecht K
    Retrovirology; 2009 Apr; 6():37. PubMed ID: 19368703
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human endogenous retrovirus type W envelope protein inhibits oligodendroglial precursor cell differentiation.
    Kremer D; Schichel T; Förster M; Tzekova N; Bernard C; van der Valk P; van Horssen J; Hartung HP; Perron H; Küry P
    Ann Neurol; 2013 Nov; 74(5):721-32. PubMed ID: 23836485
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endogenous retroviral genes, Herpesviruses and gender in Multiple Sclerosis.
    Perron H; Bernard C; Bertrand JB; Lang AB; Popa I; Sanhadji K; Portoukalian J
    J Neurol Sci; 2009 Nov; 286(1-2):65-72. PubMed ID: 19447411
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Do Antiretroviral Drugs Protect From Multiple Sclerosis by Inhibiting Expression of MS-Associated Retrovirus?
    Morandi E; Tanasescu R; Tarlinton RE; Constantin-Teodosiu D; Gran B
    Front Immunol; 2018; 9():3092. PubMed ID: 30740110
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The neutralizing antibody GNbAC1 abrogates HERV-W envelope protein-mediated oligodendroglial maturation blockade.
    Kremer D; Förster M; Schichel T; Göttle P; Hartung HP; Perron H; Küry P
    Mult Scler; 2015 Aug; 21(9):1200-3. PubMed ID: 25480862
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A phase IIa randomized clinical study testing GNbAC1, a humanized monoclonal antibody against the envelope protein of multiple sclerosis associated endogenous retrovirus in multiple sclerosis patients - a twelve month follow-up.
    Derfuss T; Curtin F; Guebelin C; Bridel C; Rasenack M; Matthey A; Du Pasquier R; Schluep M; Desmeules J; Lang AB; Perron H; Faucard R; Porchet H; Hartung HP; Kappos L; Lalive PH
    J Neuroimmunol; 2015 Aug; 285():68-70. PubMed ID: 26198921
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of Proinflammatory Multiple Sclerosis-Associated Retrovirus Envelope Protein by Human Herpesvirus-6A and CD46 Receptor Engagement.
    Charvet B; Reynaud JM; Gourru-Lesimple G; Perron H; Marche PN; Horvat B
    Front Immunol; 2018; 9():2803. PubMed ID: 30574140
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new therapeutic approach for type 1 diabetes: Rationale for GNbAC1, an anti-HERV-W-Env monoclonal antibody.
    Curtin F; Bernard C; Levet S; Perron H; Porchet H; Médina J; Malpass S; Lloyd D; Simpson R;
    Diabetes Obes Metab; 2018 Sep; 20(9):2075-2084. PubMed ID: 29749030
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rescuing the negative impact of human endogenous retrovirus envelope protein on oligodendroglial differentiation and myelination.
    Göttle P; Förster M; Gruchot J; Kremer D; Hartung HP; Perron H; Küry P
    Glia; 2019 Jan; 67(1):160-170. PubMed ID: 30430656
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lack of immune responses against multiple sclerosis-associated retrovirus/human endogenous retrovirus W in patients with multiple sclerosis.
    Ruprecht K; Gronen F; Sauter M; Best B; Rieckmann P; Mueller-Lantzsch N
    J Neurovirol; 2008 Apr; 14(2):143-51. PubMed ID: 18444086
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The envelope protein of a human endogenous retrovirus-W family activates innate immunity through CD14/TLR4 and promotes Th1-like responses.
    Rolland A; Jouvin-Marche E; Viret C; Faure M; Perron H; Marche PN
    J Immunol; 2006 Jun; 176(12):7636-44. PubMed ID: 16751411
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation between disease severity and in vitro cytokine production mediated by MSRV (multiple sclerosis associated retroviral element) envelope protein in patients with multiple sclerosis.
    Rolland A; Jouvin-Marche E; Saresella M; Ferrante P; Cavaretta R; Créange A; Marche P; Perron H
    J Neuroimmunol; 2005 Mar; 160(1-2):195-203. PubMed ID: 15710473
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.